Your browser doesn't support javascript.
loading
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation.
Kim, Joseph W; Cardin, Dana B; Vaishampayan, Ulka N; Kato, Shumei; Grossman, Steven R; Glazer, Peter M; Shyr, Yu; Ivy, S Percy; LoRusso, Patricia M.
Affiliation
  • Kim JW; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Cardin DB; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vaishampayan UN; Medical Oncology, University of Michigan, Ann Arbor, Michigan, USA.
  • Kato S; Medical Oncology, University of California San Diego, San Diego, California, USA.
  • Grossman SR; Hematology/Oncology, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Glazer PM; Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Shyr Y; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee, USA.
  • Ivy SP; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA.
  • LoRusso PM; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
Oncologist ; 26(7): e1104-e1109, 2021 07.
Article in En | MEDLINE | ID: mdl-33742489
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Pancreatic Neoplasms / Adenocarcinoma Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Pancreatic Neoplasms / Adenocarcinoma Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States